BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma Z, Jiang L, Li B, Liang D, Feng Y, Liu L, Jiang C. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity. Bioorg Med Chem 2021;46:116352. [PMID: 34403955 DOI: 10.1016/j.bmc.2021.116352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Şahin S, Can NN. A Schiff Base with Polymorphic Structure (Z′ = 2): Investigations with Computational Techniques and in Silico Predictions. Polycyclic Aromatic Compounds 2023. [DOI: 10.1080/10406638.2022.2161585] [Reference Citation Analysis]
2 Khvostov MV, Gladkova ED, Borisov SA, Fedotova MS, Zhukova NA, Marenina MK, Meshkova YV, Valutsa N, Luzina OA, Tolstikova TG, Salakhutdinov NF. 9-N-n-alkyl Berberine Derivatives: Hypoglycemic Activity Evaluation. Pharmaceutics 2022;15:44. [PMID: 36678673 DOI: 10.3390/pharmaceutics15010044] [Reference Citation Analysis]
3 Yue H, Hu Z, Hu R, Guo Z, Zheng Y, Wang Y, Zhou Y. ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism. Front Oncol 2022;12:918778. [DOI: 10.3389/fonc.2022.918778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Feng LS, Su WQ, Cheng JB, Xiao T, Li HZ, Chen DA, Zhang ZL. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021). Arch Pharm (Weinheim) 2022;:e2200051. [PMID: 35385159 DOI: 10.1002/ardp.202200051] [Reference Citation Analysis]